药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Amifostine
Levacetylmethadol
The risk or severity of QTc prolongation can be increased when Levacetylmethadol is combined with Romidepsin.
Amifostine
Indenolol
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Romidepsin.
Amifostine
Dexverapamil
The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Romidepsin.
Amifostine
Penfluridol
The risk or severity of QTc prolongation can be increased when Penfluridol is combined with Romidepsin.
Amifostine
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine is combined with Romidepsin.
Amifostine
Lorcainide
The risk or severity of QTc prolongation can be increased when Lorcainide is combined with Romidepsin.
Amifostine
Bunaftine
The risk or severity of QTc prolongation can be increased when Bunaftine is combined with Romidepsin.
Amifostine
Nizofenone
The risk or severity of QTc prolongation can be increased when Nizofenone is combined with Romidepsin.
Amifostine
Otilonium
The risk or severity of QTc prolongation can be increased when Otilonium is combined with Romidepsin.
Amifostine
Sultopride
The risk or severity of QTc prolongation can be increased when Sultopride is combined with Romidepsin.
Amifostine
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Sitafloxacin is combined with Romidepsin.
Amifostine
Oxatomide
The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Romidepsin.
Amifostine
Abexinostat
The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Romidepsin.
Amifostine
Mizolastine
The risk or severity of QTc prolongation can be increased when Mizolastine is combined with Romidepsin.
Amifostine
Ricolinostat
The risk or severity of QTc prolongation can be increased when Ricolinostat is combined with Romidepsin.
Amifostine
Simendan
The risk or severity of QTc prolongation can be increased when Simendan is combined with Romidepsin.
Amifostine
CUDC-101
The risk or severity of QTc prolongation can be increased when CUDC-101 is combined with Romidepsin.
Amifostine
Gilteritinib
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Romidepsin.
Amifostine
Entinostat
The risk or severity of QTc prolongation can be increased when Entinostat is combined with Romidepsin.
Amifostine
Mocetinostat
The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Romidepsin.